Onderneming Celyad Oncology SA OTC Markets
Aandelen
CYADY
US1512052002
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 18
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cardiology
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe and United States
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 24-07-07 |
David Georges
DFI | Director of Finance/CFO | - | 01-01-19 |
Eytan Breman
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-15 |
An Phan
LAW | General Counsel | 49 | 01-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 24-07-07 |
Hilde Windels
CHM | Chairman | 59 | 07-05-18 |
Serge Goblet
BRD | Director/Board Member | - | 01-01-08 |
Director/Board Member | 53 | 20-01-22 | |
Director/Board Member | - | - | |
Director/Board Member | 50 | 06-05-20 | |
Sage Mandel
BRD | Director/Board Member | - | - |
Marina Udier
BRD | Director/Board Member | - | 11-01-11 |
Ami Patel Shah
BRD | Director/Board Member | - | 08-12-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 41 428 572 | 38 267 083 ( 92,37 %) | 0 | 92,37 % |
Bedrijfsgegevens
Celyad Oncology SA
Axis Business Park Rue André Dumont 9
1435, Mont-Saint-Guibert
+32 1 039 41 00
http://www.celyad.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+67,53% | 63,85 mld. | |
-0,77% | 41,83 mld. | |
+45,66% | 40,65 mld. | |
-10,72% | 27,12 mld. | |
+13,30% | 26,52 mld. | |
-22,79% | 18,69 mld. | |
+4,70% | 12,73 mld. | |
+24,10% | 12,11 mld. | |
+27,41% | 12,07 mld. |